Related Experiment Video
Updated: Aug 7, 2026
09:27
Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
Published on: January 5, 2016
Degradation of alpha-synuclein by proteasome
M C Bennett1, J F Bishop, Y Leng
1Experimental Therapeutics Branch, NINDS, National Institutes of Health, Bethesda, Maryland 20892, USA.
The Journal of Biological Chemistry
|November 24, 1999
Summary
Mutations in alpha-synuclein are linked to Parkinson's disease (PD). This study shows mutant alpha-synuclein degrades slower via the proteasome, potentially explaining PD pathogenesis.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Alpha-synuclein mutations are associated with Parkinson's disease (PD).
- Lewy bodies in PD contain alpha-synuclein, ubiquitin, and proteasome subunits, suggesting impaired protein degradation.
- The specific degradation pathway and kinetics of alpha-synuclein are not well understood.
Purpose of the Study:
- To investigate the degradation kinetics of wild-type and A53T mutant alpha-synuclein.
- To determine the cellular pathway responsible for alpha-synuclein degradation.
- To explore the implications of degradation rates for PD pathogenesis.
Main Methods:
- Transient transfection of SH-SY5Y cells with 6XHis-tagged wild-type and A53T mutant alpha-synuclein.
- Pulse-chase experiments to monitor protein degradation over 24 hours.
- Treatment with the proteasome inhibitor beta-lactone to assess pathway involvement.
Main Results:
- Degradation of both wild-type and mutant alpha-synuclein followed first-order kinetics.
- Mutant alpha-synuclein exhibited a 50% longer half-life (t1/2) compared to wild-type (p < 0.01).
- Proteasome inhibition blocked the degradation of both recombinant and endogenous alpha-synuclein.
Conclusions:
- The ubiquitin-proteasome pathway degrades both wild-type and A53T mutant alpha-synuclein.
- Slower degradation kinetics of mutant alpha-synuclein provide a mechanism for its intracellular accumulation.
- Impaired alpha-synuclein catabolism may contribute to the aggregation and pathogenesis of Parkinson's disease.
Related Concept Videos
02:18The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
02:58Regulated Protein Degradation
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
02:11Proteins: From Genes to Degradation
Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick. Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA molecules by RNA...
Transcription is the synthesis of RNA molecules by RNA...
01:32Export of Misfolded Proteins out of the ER
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
01:13The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...